Psoriasis Flashcards
what is it?
a very common immune-mediated disease which is chronic - no cure, severity varies between patients
what causes it?
multifactorial
genetic and environmental (stress/drugs/infection)
what are the types?
chronic plaque psoriasis (most common)
guttate
palmoplantar pustular
erythrodermic/widespread pustular (rare)
what is the prognosis?
life expectancy reduced by 4 years in patients with severe psoriasis
mainly due to increased CV risk (3x increased risk of MI)
how does chronic plaque psoriasis present?
symmetrical sharply demarcated (well-defined) scaly erythematous plaques common sites are extensors (elbow/ knee) scalp sacrum hands feet trunk nails
how does psoriartic nail disease present?
oncholysis
nail pitting
dystrophy
subungual hyperkeratosis
what is the koebner phenomenon?
psoriasis develops in area of skin trauma e.g. stretch mark or scar
what is the auspitz sign?
removal of surface scale reveals tiny bleeding points (dilated capillaries in elongated dermal papillae)
Potential comorbidities
psoriatic arthritis metabolic syndrome (obesity, hbp, diabetes, lipid abnormalities) crohn's disease cancer depression uveitis
what is the aim in psoriasis treatment?
to control chronic disease and manage flares
1st line is dependent on the type and severity of the psoriasis
GP treatment of psoiasis - topical therapies
Emollients: given to everyone
Vitamin D analogues: for localised plaques (rather than flexures as for this it can be a little irritating) e.g. calcipotriol [Dovonex], calcitriol [Silkis] - this one is less irritating so is better for flexures
Coal tar: anywhere, no limit to amount (messy and smelly)
Dithranol: if few localised plaques and patient complies/short contact (effective but can be irritant - burn, and stains normal skin)
Steroid ointment: usually in combination, there is a risk of rebound with potent steroid ointment
specialist supervision therapies
Phototherapy: narrowband UVB and PUVA
Systemic treatments: immunosuppression e.g. methotrexate
Immune modulation: e.g. targeted biological agents